Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Derma Sciences to complete enrollment in phase II trial of DSC-127

Sep. 17, 2010

PAF-R is potential target to treat psoriasis

Sep. 17, 2010

Mimetica describes new melanocortin MC1 receptor agonists

Sep. 16, 2010

BT-061 improves psoriasis in double-blind trial

Sep. 16, 2010

Capstone presents update on trials of AZX-100 in keloid scarring

Sep. 15, 2010

Biotie reports on phase I study of BTT-1023 in plaque psoriasis

Sep. 15, 2010

New histamine H4 receptor ligand VUF-11488 to be tested in inflammation models

Sep. 13, 2010

Primary endpoint met in Renovo's phase I safety studies of Juvista after keloid excision

Sep. 10, 2010

Biofrontera reports increase of capital

Sep. 7, 2010

FDA approves additional strengths of Medicis's Solodyn for acne vulgaris

Aug. 31, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...